Skip to content

Effect of Personalized Homoeopathic Treatment on Ringworm Skin Infection Dermatophytosis With Dermatophytosis Severity score

Effectiveness of Individualized Homoeopathic Medicines In LM Potency In Patients With Dermatophytosis Assessed Using Dermatophytosis severity score - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099190
Enrollment
38
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicines In LM Potencies: Medicine will be prescribed based on selected similimum In LM potencies the procedure is one globule of selected potency is disso

Sponsors

JIMS Homoeopathic Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients included in the study were adults aged between 18 to 60 years who were clinically diagnosed with dermatophytosis such as tinea corporis tinea cruris or tinea faciei and the diagnosis was based on KOH test or clinical judgment They had not taken any systemic or topical antifungal treatment in the last two weeks before enrolment and they were willing to comply with all follow up visits for the full duration of the study

Exclusion criteria

Exclusion criteria: Patients were excluded if they had complicated dermatophytosis such as secondary bacterial infection or widespread or recalcitrant disease or if they were immunocompromised including known cases of HIV AIDS uncontrolled diabetes or those receiving immunosuppressive therapy Pregnant and lactating women were not included and patients with chronic skin conditions like psoriasis or eczema that could interfere with assessment were also excluded Individuals on conventional antifungal treatment or other alternative therapies at the time of enrolment were not considered and those with any known allergy or sensitivity to homeopathic or other medicines were also excluded

Design outcomes

Primary

MeasureTime frame
Dermatophytosis Severity ScoreTimepoint: The scale will be used At baseline and every 21 days for 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Madavi Chandana Sai

JIMS Homoeopathic medical college and hospital

ravinderpenchala@gmail.com9949438738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026